No One Owns the Cure
Executive SummaryIn 2025, Canada logged 5,461 measles cases and lost the elimination status it had held since 1998 — with two infant deaths, and 1,063 more cases by May 2026.2,3 This happened in a country that knows exactly how to prevent measles. The knowledge was never missing. What changed is whom people trust, and the fact that a health decision has hardened into an identity marker.
The familiar response — a better pamphlet, a federal podium, one more campaign — pushes a single centralized lever, and it keeps failing, because the levers that actually move uptake are dispersed across independent owners who answer to no one another. The crisis is routinely misdiagnosed as a communications problem. It is a coordination problem, with a six-part anatomy no single actor controls. The Public Health Agency can fund and guide but cannot mandate a province’s data system or a clinic’s billing codes; a province can legislate but works from blind, localized data; a platform controls the algorithm but holds no public-health mandate.
Each holds one lever; none can reach the rest.
Two problems wear one coat. The demand-side problem — the roughly one in five whose refusal is a fortified identity — is genuinely intractable in the short term, and no campaign un-sorts it. The coordination-side problem is architectural, and highly tractable. The strategic move is not to convert the ideological core but to synchronize the institutional defense, protect the hesitant-but-reachable middle, and cross the 95 percent line — which renders the residual core epidemiologically harmless without converting anyone. This paper is candid about the first problem and focused on the second: it lays out the six-part anatomy, names the village that spans it, and describes the one mechanism that resolves all six at once — putting the constraint-owning actors in a single room and forcing a decision before the next respiratory season opens.
The Cost Is Measurable — in Lives, Beds, Dollars, and Trust.
Before 2020, a working consensus — federal guidance, provincial delivery, and trusted family doctors — held coverage high and kept measles eliminated. That consensus has fractured, and the cost is now countable. The numbers describe a system that understands its problem and has not yet been able to act on it together. An outbreak that began in late 2024 spread across several provinces through 2025, concentrated among unvaccinated children, and cost the country a status it had held for a quarter of a century.2,3
A case count is the abstraction. The cost is what the count is made of. The outbreak fell almost entirely on the unprotected — roughly seven in eight of those infected were unvaccinated — and it concentrated where coverage had slipped furthest, with the large majority of 2025 cases in just two provinces.18 The human toll is the part that does not appear in a coverage table: infants have died, and a disease most Canadians had filed under “solved” has fallen hardest on newborns and pregnant patients.19
The structural vulnerability beneath the outbreak is a coverage figure that has slipped below the line. Two-dose MMR coverage at age two stands at 85.3 percent — roughly ten points below the 95 percent herd-immunity threshold the WHO treats as the floor for measles control — and DTaP sits at 78.4 percent.4 None of this reflects an absence of knowledge about what protects a population. It reflects how many separate hands must move for that knowledge to reach an arm.
Set the economics side by side and the picture turns almost absurd. Containing 16 cases in a 2015 Ontario episode cost roughly $1.2 million; a publicly funded dose costs around $30.6 Prevention is not merely the humane choice — it is cheaper by orders of magnitude, which is precisely why a coordination failure that lets uptake slip is so expensive a way to save money.
The cost lands in a fourth currency too: confidence, and the time of the people who hold it. Trust in scientists sits at 78 percent and absolute vaccine refusal at 21 percent; 46 percent of Canadians say AI makes information less trustworthy; and 97 percent of physicians report having to counter patient misinformation.5,15 The most-trusted messenger in the system is spending unpaid time fighting a rising tide of falsehood.
And in much of the country, the system cannot even see the problem clearly enough to act. Whether a province can tell the public how protected its children are turns out to vary as much as the coverage itself: only five of ten provinces, and one of three territories, report comparable real-time coverage data.4 A country that cannot see its own coverage is fighting an outbreak partly blindfolded — the first hint that this is coordination, not knowledge. The system cannot even see itself.
So the cost is plain — in lives, in suffering, in beds, in dollars, and in trust — the math favours prevention overwhelmingly, and the answers are well known. A problem this legible ought to be a problem already being solved. That it is not points to a misdiagnosis.
It Was Never a Knowledge Problem — and the Problem Has a Six-Part Anatomy.
Knowledge was already widespread before the pandemic; as far back as 2019, more than nine in ten Canadians believed vaccines were effective.7 What changed is whom people trust, and the fact that a health decision became an identity marker. The familiar institutional response — better pamphlets, a federal podium, a single campaign — pushes one centralized lever and keeps failing, because the levers that actually matter are dispersed across independent owners.
Why smart people keep choosing the wrong tool
This is worth stating with empathy, not blame. The challenge is complex, in the precise sense: many interdependent actors, no linear cause and effect, outcomes that emerge only from the interaction of the parts. But it presents like a complicated problem — one with a knowable expert answer — or even a simple one (“the facts are clear; just communicate harder”). The trap is natural and sympathetic. For obvious and complicated problems, the right move genuinely is to analyze and prescribe a single best answer, so reaching for more expertise, a sharper campaign, or one authoritative messenger feels not just reasonable but responsible. That instinct is exactly what fails here. Complex problems do not yield to a single expert lever; they require probing across many levers at once, sensing what responds, and coordinating the actors who each hold a piece — the opposite of “communicate harder.” Naming the mismatch reframes a decade of well-intentioned single-lever effort not as incompetence but as the right tool applied to the wrong kind of problem.
Name the structure, then. The crisis decomposes into six interdependent variables that cannot be solved alone or in sequence. Together they account for nearly the whole of the problem:
Continental ideological weather. The northward drift of well-funded U.S. anti-vaccine networks, with Canadian counterparts using litigation and propaganda. The pressure is regional, but the weather system is continental.
The information and algorithm ecosystem. Engagement-optimized amplification, AI-generated falsehoods, and the speed asymmetry between a viral claim and a peer-reviewed correction.
Fragmented measurement and visibility. No unified registry; thirteen disparate systems; reliance on lagging biennial surveys. The system cannot reliably see where protection has thinned.
Jurisdictional and governance fragmentation. A federal/provincial split in which only three provinces mandate school-entry measles vaccination, producing duplicated and sometimes conflicting effort.
Provider trust and front-line capacity. The most-trusted messenger — the family doctor — is uncompensated for the trust-building conversation, overstretched, and burning out.
Access, equity, and community realities. Distinct barriers for Indigenous, newcomer, and rural populations, in a landscape where trust has relocated to the local.
Each variable has a different owner, and no single actor controls more than one lever.
That is the crux. The Public Health Agency can fund and guide but cannot mandate a province’s data system or a clinic’s billing codes; a province can legislate but works from blind, localized data; a platform controls the algorithm but has no public-health mandate. The six variables are not a list of things to fix in turn. They are a single interlocking system, and that is why every single-lever response has stalled.
Be Honest About Which Half Is Solvable.
Two problems wear one coat, and the response usually addresses only the first. The demand-side problem — the roughly 15 to 20 percent whose refusal has become a fortified identity marker — is genuinely intractable in the short term. No campaign un-sorts it, and no facilitator argues a person out of it. The coordination-side problem is different in kind: it is architectural, and it is highly tractable. It is the reachable variable.
The strategic move follows directly. It is not to convert the ideological core but to synchronize the institutional defense, protect the hesitant-but-reachable middle, and cross 95 percent — which renders the residual core epidemiologically harmless without converting it. Naming the split candidly is what makes the rest of this paper credible to a sophisticated reader: it defines, precisely, what winning can and cannot mean.
What Would It Take to Win — and Who Has to Decide Together?
Posed directly: how does a country whose levers of influence — data, clinical capacity, platform rules, community trust — are dispersed across independent actors with no shared authority actually reverse the slide?
Anchor the question in a concrete winning aspiration: re-establish resilience against vaccine-preventable disease by restoring childhood coverage above herd-immunity thresholds. Make it measurable with the targets the answer must hit.
- MMR at age 2: from 85.3 percent to at least 95 percent by 2028.
- Real-time interoperable data: from 6 of 13 to all 13 jurisdictions by 2027.
- Measles cases: from 5,461 in 2025 to fewer than 50 (import-only) by 2027.
- Physician misinformation burden: from 97 percent to under 50 percent by 2028.
- Trust in scientists: from 78 percent to above 85 percent; hardline refusal from 21 percent to under 10 percent by 2028.
This converts “is this hopeless?” into something answerable: here is a defined finish line, and the real question is who must move together to reach it.
Put the Village in One Room and Solve All Six at Once.
The answer is not another campaign, advisory body, or summit. It is a decision-forcing session that assembles the constraint-owning village and works all six variables simultaneously, because they cannot be solved in isolation or in sequence. Each instrument the system usually reaches for is built for an earlier stage of the work: a campaign sharpens a message, an advisory body produces recommendations, a summit builds relationships. The trust problem has travelled past all three, into territory where progress depends on named owners and resolved trade-offs.
Who is in the room — the village, each owning one lever:
The minimum viable room is Data plus Delivery plus Digital. Adversarial actors — Children’s Health Defense, Vaccine Choice Canada — are to be understood and countered, never convened.
How the room works: Analyze → Diverge → Converge
Analyze. Surface the real constraints and align on facts — the six variables, and the 95 percent target. The work of the stage is not to re-establish the numbers but to use them to expose how thoroughly the response is split across owners who each see only part of it.
Diverge. Generate options across all six variables in parallel, in small, cognitively diverse teams — combinations no single actor, defending its own role, would reach alone.
Converge. Resolve the trade-offs and produce a 30/60/90-day plan with named owners and committed accountability — not a communiqué. Because uptake is measurable and the season is dated, every commitment can be attached to a baseline and a deadline.
Why this beats the alternatives: an information campaign pushes one lever; a standing advisory body produces a report it cannot make provinces fund; an annual summit produces non-binding alignment that stays at the altitude it was reached. Only forced convergence closes the strategy-execution gap.
One Variable, One Room.
Each of the six variables is itself complex enough to be its own Mind Meeting, with its own framing question and its own Analyze → Diverge → Converge pass. To show what working a single lever actually looks like — and why structured convergence beats the obvious move — take Variable 5: provider trust and front-line capacity.
How do we keep the country’s most-trusted vaccine messenger in the conversation, when the conversation itself isn’t a billable act?
Analyze — surface the real constraint. The family physician is the most trusted and most effective influence on a hesitant parent, yet the trust-building conversation — ten unhurried minutes addressing a specific fear — is uncompensated, competes with a full panel, and lands on a workforce already burning out. The instinct (“give doctors better materials”) misreads the constraint: the issue is not what physicians know or can hand out, it is that the system does not pay for the one thing that works.
Diverge — generate options across the whole lever, not the obvious one. In cognitively diverse teams: a dedicated vaccine-confidence consult fee code; group and well-child visit redesign; standing-order delegation to nurses and pharmacists; a shared point-of-care decision aid; standard-of-care guidance that gives clinicians cover; protected-time models. The default — a physician toolkit, more continuing education — is on the wall, but now as one option among many, and visibly the weakest, because it adds burden without removing the binding constraint.
Converge — resolve the trade-off and commit. The constraint-owners in the room — provincial payers, medical associations, public health — land on a compensated “vaccine-confidence consult” code paired with a shared decision aid and standard-of-care cover, with named owners and a 30/60/90-day path to a pilot. The non-obvious answer wins because the people who control the fee schedule are in the room to say yes. A communications problem turned out to be a payment-design problem — exactly the kind of reframe a structured room produces and a campaign never would.
That this single variable sustains its own full framing question and ADC pass is the point. The crisis is not one Mind Meeting but a portfolio of them — which is why no single actor, working one lever in isolation, has been able to move it. The same test applies to the other five. Two quick illustrations of obvious-default versus converged answer: for fragmented measurement, the default is to build one national registry — attempted, and stalled for two decades; the converged answer is a thin interoperability layer across the existing thirteen systems, because the binding constraint is jurisdictional sovereignty, not technology. For access and community, the default is a targeted outreach campaign; the converged answer is funded delegation of delivery to trusted local and Indigenous-led partners, because trust has relocated to the local and the lever is who delivers, not what is said.
The Question Before the Season Opens.
The demand half is hard: a politically sorted reluctance that no campaign, study, or workshop will argue away. That part is not the claim of this paper. The coordination half is reachable — and the respiratory season is coming. The answers exist; the data is in hand; the people who would need to act are, for the most part, willing. What is missing is the room: the setting that brings those willing parties, and the local messengers the public still trusts, to a shared decision before the moment passes. No single actor could produce that result alone, and none can substitute for it. That is not a verdict on any of them; it is the structure of the problem.
No single actor owns the cure. The cure is owned in common, or not at all.
Start a Conversation.
If this is the shape of the challenge — a trust gap that is really a coordination gap, with a season as its deadline — the next step is a structured process. A Mind Meeting convenes the internal team alongside the full village that governs the constraints, surfaces each variable, forces the trade-offs, and produces a 30/60/90-day plan with named owners. The analysis is done and the goodwill is real. The remaining work is coordination, and it has a known shape and a known instrument.
Mark McCarvill is the founder of Mind Meeting Group, a Vancouver-based strategy and facilitation firm. He has led more than 100 strategic workshops, aligned more than 3,000 leaders and stakeholders, and worked on challenges touching more than $350 billion in portfolio value, including engagements with seven of the global top-twelve pharmaceutical companies. Mind Meeting Group specializes in complex, multi-stakeholder challenges where the answer is knowable but not yet executable — and where the right process, not more analysis, is what converts strategy into committed action.
In the health-system domain, MMG has convened multi-stakeholder workshops on diagnostic and therapeutic access in Canada — including a cross-sector strategy for MRI access for early-Alzheimer’s patients that produced 19 prioritized recommendations, and a national care-pathway workshop that aligned clinicians, advocates, home-care providers, and provincial policy actors around 18 consensus recommendations — working with clinicians, pharmacists, payers, patient advocates, and policy experts to turn rigorous analysis into coalition-ready, executable plans.
- Canada co-hosts the FIFA World Cup 2026 (June 11–July 19, 2026), with matches in Toronto (BMO Field) and Vancouver (BC Place): FIFA; Government of Canada, 2026.
- Canada’s loss of measles elimination status: Public Health Agency of Canada, “Statement on Canada’s Measles Elimination Status,” November 2025.
- Case counts (147 in 2024; more than 5,000 in 2025) and the outbreak originating in late 2024: PHAC, Canadian Measles and Rubella Surveillance System / Measles and Rubella Weekly Monitoring Report, 2025.
- Two-dose MMR coverage at age seven falling from 85.4% to 74.9% (2019–2023), against the ~95% threshold for measles control, and published only as a national blend across reporting jurisdictions: A. Jeevakanthan et al., “Routine vaccination coverage at ages 2 and 7, before, during, and after the COVID-19 pandemic: Results from the STARVAX surveillance system,” Canadian Journal of Public Health (2025, corrected).
- Roughly one-quarter of Canadians declining a physician-recommended vaccine (24%), continued high trust in family doctors, and the partisan gradient (about 39% of Conservative supporters versus 12–14% of others): Angus Reid Institute survey, May 2026 (reported in Canadian press).
- Hospitalizations for vaccine-preventable respiratory diseases more than doubling in 2024–25 (142 per 100,000), with COVID-19 accounting for over 40% (25,501) at an average $28,500 and 23 days per patient: Canadian Institute for Health Information, “Hospitalizations for vaccine-preventable respiratory diseases surpass pre-pandemic levels,” April 16, 2026.
- Strong pre-pandemic belief in vaccine effectiveness (more than nine in ten Canadians in 2019) and the “parental choice” argument running roughly twice as high in the Conservative sphere as in the Liberal or NDP spheres: Angus Reid Institute vaccine-confidence tracking, 2019.
- The “Crisis of Grievance” — a public mood defined by the belief that the system is rigged and that government and corporate leadership are indifferent to ordinary people, bleeding from economic into health perceptions: Edelman Trust Barometer, 2025–26.
- Collapse in strong support for proof-of-vaccination measures (66.0% to 43.1%) around the Omicron wave, hardening opposition, and the public split on the Freedom Convoy (roughly one-third viewing it as genuine public anger): peer-reviewed study of Canadian attitudes toward COVID-19 vaccine mandates, 2022 (PMC).
- The relocation of trust toward local and personal sources (own clinician, pharmacist, employer, community) over central government and national media, and the decline of trust in media health reporting into distrust territory (~39%): Edelman Trust Barometer and Canadian trust-in-science synthesis, 2024–26.
- Provincial variation in refusal — Alberta highest at roughly 35% (the least trusting province over a decade of polling) and Quebec lowest near 19% (correlating with higher generalized social trust): CanTrust Index / Leger Healthcare, 2025–26.
- U.S. federal actions — replacement of the membership of the CDC’s Advisory Committee on Immunization Practices (June 2025); cancellation of roughly US$500 million in mRNA vaccine research (August 2025); removal of COVID-19 vaccines from the routine schedule for healthy children and pregnant people (May 2025): U.S. Department of Health and Human Services; reporting by NPR and STAT, 2025.
- FDA narrowing of COVID-19 vaccine eligibility by age and risk status (2025), and the objection of twelve former FDA commissioners (December 2025): NPR; BioPharma Dive, 2025.
- Organized anti-vaccine networks operating across the Canada–U.S. border (e.g., Vaccine Choice Canada and affiliated groups): Canadian public-interest reporting (CBC), 2024–25.
- Limits of the information-deficit approach and of messaging-only coalitions (e.g., ScienceUpFirst, 19 To Zero) that amplify a message without convening binding cross-actor delivery, and the roughly 40% of front-line clinicians confident in addressing hesitancy: Leger Healthcare provider survey and Canadian program reviews, 2025–26.
- Seasonal respiratory franchise strategy and a flu/COVID combination under review in Canada: Moderna business and pipeline update, 44th Annual J.P. Morgan Healthcare Conference, January 2026.
- Pharmacist authority to immunize in Canada since 2012 and the positive effect of pharmacist-led immunization on uptake: systematic review and meta-analysis of pharmacist interventions on immunization uptake (peer-reviewed), 2024.
- Roughly 87–90% of those infected during the 2024–26 outbreak were unvaccinated, and approximately 84% of 2025 cases were in Ontario and Alberta: PHAC, Measles and Rubella Weekly Monitoring Report, 2025; provincial health ministries.
- Infant deaths during the outbreak (including congenital measles) and the disproportionate burden on newborns and pregnant patients, reported in aggregate: CMAJ; CBC News and CIDRAP reporting, 2025. Figures are presented in aggregate to protect the privacy of affected families.